Abstract: A package containing a stack of folded disposable absorbent articles, the package being formed of flexible polymeric film, and having a path of perforations or scoring defining a hood opening structure, is disclosed. The hood opening structure may be configured to open proximate the fold noses of the articles for easy tactile identification, grasping and withdrawal of individual ones thereof, and may be configured so as to serve as an effective package reclosure device whereby the package may be used to store the unused supply of articles following opening. The package, and printed commercial artwork and product information on the package surfaces, may be configured such that the fold noses are disposed at the apparent bottom of the package, for improved standing stability when the package is shelved.

Abstract: A package containing a stack of folded disposable absorbent articles, the package being formed of flexible polymeric film, and having a path of perforations or scoring defining a hood opening structure, is disclosed. The hood opening structure may be configured to open proximate the fold noses of the articles for easy tactile identification, grasping and withdrawal of individual ones thereof, and may be configured so as to serve as an effective package reclosure device whereby the package may be used to store the unused supply of articles following opening. The package, and printed commercial artwork and product information on the package surfaces, may be configured such that the fold noses are disposed at the apparent bottom of the package, for improved standing stability when the package is shelved.

Abstract: A package containing a stack of folded disposable absorbent articles, the package being formed of flexible polymeric film, and having a path of perforations or scoring defining a hood opening structure, is disclosed. The hood opening structure may be configured to open proximate the fold noses of the articles for easy tactile identification, grasping and withdrawal of individual ones thereof, and may be configured so as to serve as an effective package reclosure device whereby the package may be used to store the unused supply of articles following opening. The package, and printed commercial artwork and product information on the package surfaces, may be configured such that the fold noses are disposed at the apparent bottom of the package, for improved standing stability when the package is shelved.

Abstract: A package containing a stack of folded disposable absorbent articles, the package being formed of flexible polymeric film, and having a path of perforations or scoring defining a hood opening structure, is disclosed. The hood opening structure may be configured to open proximate the fold noses of the articles for easy tactile identification, grasping and withdrawal of individual ones thereof, and may be configured so as to serve as an effective package reclosure device whereby the package may be used to store the unused supply of articles following opening. The package, and printed commercial artwork and product information on the package surfaces, may be configured such that the fold noses are disposed at the apparent bottom of the package, for improved standing stability when the package is shelved.

Abstract: An array of at least two commonly-branded absorbent articles, such as wipes products. The array includes a first wipes product and a second wipes product. Each wipes product may appeal to a different type of consumer, such as a light experience seeking consumer and a heavy experience seeking consumer. The first wipes product may include a first supply of wipes formed from a first substrate. The first supply of wipes is moistened with a first functional lotion composition including a first fragrance accord and a first lotion formula. The second wipes product may include a second supply of wipes formed from a second substrate. The second supply of wipes is moistened with a second functional lotion composition including a second fragrance accord and a second lotion formula. The second fragrance accord is different from the first fragrance accord, and the second lotion formula is different from the first lotion formula.

Abstract: An array of at least two commonly-branded absorbent articles, such as wipes products. The array includes a first wipes product and a second wipes product. Each wipes product may appeal to a different type of consumer, such as a light experience seeking consumer and a heavy experience seeking consumer. The first wipes product may include a first supply of wipes formed from a first substrate. The first supply of wipes is moistened with a first functional lotion composition including a first fragrance accord and a first lotion formula. The second wipes product may include a second supply of wipes formed from a second substrate. The second supply of wipes is moistened with a second functional lotion composition including a second fragrance accord and a second lotion formula. The second fragrance accord is different from the first fragrance accord, and the second lotion formula is different from the first lotion formula.

Abstract: An array of at least two commonly-branded absorbent articles, such as wipes products. The array includes a first wipes product and a second wipes product. Each wipes product may appeal to a different type of consumer, such as a light experience seeking consumer and a heavy experience seeking consumer. The first wipes product may include a first supply of wipes formed from a first substrate. The first supply of wipes is moistened with a first functional lotion composition including a first fragrance accord and a first lotion formula. The second wipes product may include a second supply of wipes formed from a second substrate. The second supply of wipes is moistened with a second functional lotion composition including a second fragrance accord and a second lotion formula. The second fragrance accord is different from the first fragrance accord, and the second lotion formula is different from the first lotion formula.

Abstract: An array of at least two commonly-branded absorbent articles, such as wipes products. The array includes a first wipes product and a second wipes product. Each wipes product may appeal to a different type of consumer, such as a light experience seeking consumer and a heavy experience seeking consumer. The first wipes product may include a first supply of wipes formed from a first substrate. The first supply of wipes is moistened with a first functional lotion composition including a first fragrance accord and a first lotion formula. The second wipes product may include a second supply of wipes formed from a second substrate. The second supply of wipes is moistened with a second functional lotion composition including a second fragrance accord and a second lotion formula. The second fragrance accord is different from the first fragrance accord, and the second lotion formula is different from the first lotion formula.

Abstract: A wearable article with an extensible fastening member having a fastener proximate its end is disclosed. The fastening member may be highly extensible, and may have construction features and shape characteristics that affect distribution of force components when the fastener is in use, and reduce the chances of buckling or flipping of the fastening member along its edges, and the chances that the edges of the fastener will be lifted away from a surface to which it is attached. The fastener and material forming an accompanying landing zone on the article may be selected to form a fastening combination having performance attributes that provide further resistance to unintended pop-off under wearing conditions.

Abstract: The present invention is directed to the identification of markers that can be used to determine whether tumors are sensitive or resistant to a therapeutic agent. The present invention is also directed to the identification of therapeutic targets. The invention features a number of “sensitivity markers.” These are markers that are expressed in most or all cell lines that are sensitive to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are resistant to treatment with that agent. The invention also features a number of “resistance markers.” These are markers that are expressed in most or all cell lines that are resistant to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are sensitive to treatment with that agent. The invention also features marker sets that can predict patients that are likely to respond or not to respond to an agent.

Abstract: The present invention is directed to the identification of markers that can be used to determine whether tumors are sensitive or resistant to a therapeutic agent. The present invention is also directed to the identification of therapeutic targets. The invention features a number of “sensitivity markers.” These are markers that are expressed in most or all cell lines that are sensitive to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are resistant to treatment with that agent. The invention also features a number of “resistance markers.” These are markers that are expressed in most or all cell lines that are resistant to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are sensitive to treatment with that agent. The invention also features marker sets that can predict patients that are likely to respond or not to respond to an agent.

Abstract: The present invention is directed to the identification of markers that can be used to determine whether tumors are sensitive or resistant to a therapeutic agent. The present invention is also directed to the identification of therapeutic targets. The invention features a number of “sensitivity markers.” These are markers that are expressed in most or all cell lines that are sensitive to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are resistant to treatment with that agent. The invention also features a number of “resistance markers.” These are markers that are expressed in most or all cell lines that are resistant to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are sensitive to treatment with that agent. The invention also features marker sets that can predict patients that are likely to respond or not to respond to an agent.

Abstract: A method for measuring the force necessary to separate a sample of a hooks fastener component from engagement with a loops component is disclosed. The method includes the steps of engaging respective samples of the hooks material and loops material along a plane of engagement, displacing them in a shear direction parallel with the plane of engagement, pulling them apart on a tensile tester in a direction orthogonal to the plane of engagement, until disengaged, and measuring the pulling force exerted during the pulling step. A wearable article having a combination of hooks fastener and loops material landing zone is also disclosed, wherein the hooks fastener and loops material are selected using the disclosed method.

Abstract: A wearable article with an extensible fastening member having a fastener proximate its end is disclosed. The fastening member may be highly extensible, and may have construction features and shape characteristics that affect distribution of force components when the fastener is in use, and reduce the chances of buckling or flipping of the fastening member along its edges, and the chances that the edges of the fastener will be lifted away from a surface to which it is attached. The fastener and material forming an accompanying landing zone on the article may be selected to form a fastening combination having performance attributes that provide further resistance to unintended pop-off under wearing conditions.

Abstract: The present invention is directed to the identification of markers that can be used to determine whether tumors are sensitive or resistant to a therapeutic agent. The present invention is also directed to the identification of therapeutic targets. The invention features a number of “sensitivity markers.” These are markers that are expressed in most or all cell lines that are sensitive to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are resistant to treatment with that agent. The invention also features a number of “resistance markers.” These are markers that are expressed in most or all cell lines that are resistant to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are sensitive to treatment with that agent. The invention also features marker sets that can predict patients that are likely to respond or not to respond to an agent.

Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers. A variety of newly identified markers are provided, wherein changes in the levels of expression of one or more of the markers is correlated with the presence of breast cancer.

Abstract: A process and software for the distribution of communications in a relational context utilizing the Internet with the steps of: Each person sends an electronic newsletter to their list of personal/business contacts, each person's profile is carried on the newsletter of the first level (Parent 1) person he is in relation to, each person's profile is carried on the newsletter of the second level (Parent 2) person he is in relation to, each person's profile is carried on the newsletter of the third level (Parent 3) person he is in relation to, each person's profile is carried on the newsletter of the fourth level (Parent 4) person he is in relation to, and each person's profile is carried on the newsletter of the fifth level (Parent 5) person he is in relation to.

Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers. A variety of newly identified markers are provided, wherein changes in the levels of expression of one or more of the markers is correlated with the presence of breast cancer.

Abstract: The disclosed Near Real-Time Video (NRTV) system is a complete video processing, smart dissemination and user display capability for dissemination of video data from surveillance systems, such as manned and unmanned aerial surveillance platforms. The system requires significantly less bandwidth for dissemination than traditional, full analog video distribution. The exemplary system ingests an analog video source signal from a surveillance platform, digitizes the video, and allows a local or remote user to visualize frames of the video field of view on a standard map display. From an overlay of the field(s) of view, the system allows the user to request selected images or a video clip from the actual video surveillance information. Using available communications, the request is relayed to the video processing subsystem, and a video file of the requested information is generated and sent back to the user for display, all in near real-time.

Abstract: The present invention is directed to the identification of markers that can be used to determine whether tumors are sensitive or resistant to a therapeutic agent. The present invention is also directed to the identification of therapeutic targets. The invention features a number of “sensitivity markers.” These are markers that are expressed in most or all cell lines that are sensitive to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are resistant to treatment with that agent. The invention also features a number of “resistance markers.” These are markers that are expressed in most or all cell lines that are resistant to treatment with an agent and which are not expressed (or are expressed at a rather low level) in cells that are sensitive to treatment with that agent. The invention also features marker sets that can predict patients that are likely to respond or not to respond to an agent.